logo
AI in health care could save lives and money − but change won't happen overnight

AI in health care could save lives and money − but change won't happen overnight

Japan Today20-07-2025
By Turgay Ayer
Imagine walking into your doctor's office feeling sick – and rather than flipping through pages of your medical history or running tests that take days, your doctor instantly pulls together data from your health records, genetic profile and wearable devices to help decipher what's wrong.
This kind of rapid diagnosis is one of the big promises of artificial intelligence for use in health care. Proponents of the technology say that over the coming decades, AI has the potential to save hundreds of thousands, even millions of lives.
What's more, a 2023 study found that if the health care industry significantly increased its use of AI, up to $360 billion annually could be saved.
But though artificial intelligence has become nearly ubiquitous, from smartphones to chatbots to self-driving cars, its impact on health care so far has been relatively low.
A 2024 American Medical Association survey found that 66% of U.S. physicians had used AI tools in some capacity, up from 38% in 2023. But most of it was for administrative or low-risk support. And although 43% of U.S. health care organizations had added or expanded AI use in 2024, many implementations are still exploratory, particularly when it comes to medical decisions and diagnoses.
I'm a professor and researcher who studies AI and health care analytics. I'll try to explain why AI's growth will be gradual, and how technical limitations and ethical concerns stand in the way of AI's widespread adoption by the medical industry.
Inaccurate diagnoses, racial bias
Artificial intelligence excels at finding patterns in large sets of data. In medicine, these patterns could signal early signs of disease that a human physician might overlook – or indicate the best treatment option, based on how other patients with similar symptoms and backgrounds responded. Ultimately, this will lead to faster, more accurate diagnoses and more personalized care.
AI can also help hospitals run more efficiently by analyzing workflows, predicting staffing needs and scheduling surgeries so that precious resources, such as operating rooms, are used most effectively. By streamlining tasks that take hours of human effort, AI can let health care professionals focus more on direct patient care.
But for all its power, AI can make mistakes. Although these systems are trained on data from real patients, they can struggle when encountering something unusual, or when data doesn't perfectly match the patient in front of them.
As a result, AI doesn't always give an accurate diagnosis. This problem is called algorithmic drift – when AI systems perform well in controlled settings but lose accuracy in real-world situations.
Racial and ethnic bias is another issue. If data includes bias because it doesn't include enough patients of certain racial or ethnic groups, then AI might give inaccurate recommendations for them, leading to misdiagnoses. Some evidence suggests this has already happened.
Data-sharing concerns, unrealistic expectations
Health care systems are labyrinthian in their complexity. The prospect of integrating artificial intelligence into existing workflows is daunting; introducing a new technology like AI disrupts daily routines. Staff will need extra training to use AI tools effectively. Many hospitals, clinics and doctor's offices simply don't have the time, personnel, money or will to implement AI.
Also, many cutting-edge AI systems operate as opaque 'black boxes.' They churn out recommendations, but even its developers might struggle to fully explain how. This opacity clashes with the needs of medicine, where decisions demand justification.
But developers are often reluctant to disclose their proprietary algorithms or data sources, both to protect intellectual property and because the complexity can be hard to distill. The lack of transparency feeds skepticism among practitioners, which then slows regulatory approval and erodes trust in AI outputs. Many experts argue that transparency is not just an ethical nicety but a practical necessity for adoption in health care settings.
There are also privacy concerns; data sharing could threaten patient confidentiality. To train algorithms or make predictions, medical AI systems often require huge amounts of patient data. If not handled properly, AI could expose sensitive health information, whether through data breaches or unintended use of patient records.
For instance, a clinician using a cloud-based AI assistant to draft a note must ensure no unauthorized party can access that patient's data. U.S. regulations such as the HIPAA law impose strict rules on health data sharing, which means AI developers need robust safeguards.
Privacy concerns also extend to patients' trust: If people fear their medical data might be misused by an algorithm, they may be less forthcoming or even refuse AI-guided care.
The grand promise of AI is a formidable barrier in itself. Expectations are tremendous. AI is often portrayed as a magical solution that can diagnose any disease and revolutionize the health care industry overnight. Unrealistic assumptions like that often lead to disappointment. AI may not immediately deliver on its promises.
Finally, developing an AI system that works well involves a lot of trial and error. AI systems must go through rigorous testing to make certain they're safe and effective. This takes years, and even after a system is approved, adjustments may be needed as it encounters new types of data and real-world situations.
Incremental change
Today, hospitals are rapidly adopting AI scribes that listen during patient visits and automatically draft clinical notes, reducing paperwork and letting physicians spend more time with patients. Surveys show over 20% of physicians now use AI for writing progress notes or discharge summaries. AI is also becoming a quiet force in administrative work. Hospitals deploy AI chatbots to handle appointment scheduling, triage common patient questions and translate languages in real time.
Clinical uses of AI exist but are more limited. At some hospitals, AI is a second eye for radiologists looking for early signs of disease. But physicians are still reluctant to hand decisions over to machines; only about 12% of them currently rely on AI for diagnostic help.
Suffice to say that health care's transition to AI will be incremental. Emerging technologies need time to mature, and the short-term needs of health care still outweigh long-term gains. In the meantime, AI's potential to treat millions and save trillions awaits.
Turgay Ayer is Professor of Industrial and Systems Engineering, Georgia Institute of Technology.
The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.
External Link
https://theconversation.com/ai-in-health-care-could-save-lives-and-money-but-change-wont-happen-overnight-241551
© The Conversation
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's Export Control Playbook: More Than Just Rare Earths
China's Export Control Playbook: More Than Just Rare Earths

The Diplomat

time2 hours ago

  • The Diplomat

China's Export Control Playbook: More Than Just Rare Earths

Rare earths have recently been at the center of China-U.S. trade talks and media coverage. Given China's dominance in the global supply, these minerals are often seen as Beijing's trump card against Washington – a perception reinforced by the recent U.S. unbanning of some AI chip sales to China following Beijing's easing of rare earth controls. However, rare earths constitute only a fraction of China's broader strategic design of export controls. A closer examination of China's evolving export control regime reveals a far more expansive and systematic approach, targeting a broad spectrum of other mineral resources and advanced technologies beyond the widely discussed rare earths. Export controls have been a key economic tool in great power competition. China's rapid development and application of the regime have equipped Beijing with new sources of leverage in international negotiations and begun to impact the global economy. The key question is not whether China will implement such controls, but rather whether and how they can retain effectiveness in a shifting geopolitical landscape, including evolving global supply chains. China's Growing Interests in Export Controls China's export control regime, initially established in the early 1990s as part of its nuclear nonproliferation commitments, has gained a sharper strategic focus in recent years. A significant turning point occurred in 2020 with the enactment of the new Export Control Law, which provided a legal basis for regulating the exports of goods, technologies, and services deemed crucial to national security. Subsequent updates to the Catalogue of Technologies Prohibited or Restricted from Export (the Catalogue), including its further revision in late 2023, extended its reach into emerging high-tech domains. This institutionalization deepened in 2024 with the promulgation of the Regulations on Export Control of Dual-use Items, which introduced a unified control system, provided implementation details, and strengthened oversight of high-tech sectors. The List of Dual-use Items Subject to Export Control was then released to integrate control lists derived from pre-existing regulations and rules systematically. Over the past few years, Beijing has intensified its efforts to tighten export controls on a broader range of minerals and technologies beyond rare earths. This trend continued into 2025: amid escalating U.S. tariffs on Chinese goods, China imposed additional restrictions in February on five critical minerals – tungsten, tellurium, bismuth, molybdenum, and indium – followed by the export controls over seven key rare earths in April. In July 2025, Beijing introduced a new wave of measures, including the enactment of the Mineral Resources Law, a crackdown on the smuggling of strategic minerals, the inclusion of technologies crucial for electric vehicle batteries and nonferrous metal processing in the Catalogue, and export bans targeting eight Taiwan-based entities. Recent legal and regulatory developments have established a comprehensive legal framework that integrates interconnected laws, administrative regulations, and departmental rules across different levels. All these suggest a clear departure from China's earlier, more opaque and informal practices of export controls. While this formalization helps overcome principal-agent problems, enhances enforcement, and sends a clearer diplomatic signal to foreign actors, it also reduces policy flexibility. Legal commitments may constrain the state's ability to adjust or reverse course without incurring significant reputational or political costs associated with backing down, particularly when these measures are portrayed as defiance against Western hegemony. Strategic Use of Export Controls and Their Global Impacts China's current export control regime now extends well beyond rare earths, encompassing a wide range of technologies and minerals vital to defense and high-tech industries. It serves not only as a counter-pressure tool against the United States but also influences tech giants' business operations, as well as global trade flows and supply chains in emerging sectors. One early example was the TikTok deal. In 2020, China added personalized information push services and AI interactive interfaces – crucial to TikTok's recommendation algorithm – into the Catalogue. This move significantly complicated any foreign acquisition of the platform's underlying technologies. By requiring adherence to Chinese laws and government approval, Beijing effectively influenced the transaction of these technologies to a strategic competitor. China, the world's leading drone manufacturer, which accounts for 80 percent of the global consumer drone market, implemented export control measures to restrict foreign access to drone-related components and technologies. A typical example is U.S. drone maker Skydio: Chinese sanctions on the company in late 2024 effectively disrupted its supply chain, making it challenging to find alternative suppliers in the short term. In 2024, following Western allegations of China's support for Russia's war efforts in Ukraine, Beijing announced new drone export controls. These restrictions reportedly affected the flows of key components for unmanned aerial vehicles to the United States and Europe. China's export control regime has also expanded to encompass a broader range of mineral resources beyond rare earths, including gallium, germanium, graphite, and antimony. According to an IEA report, among the 20 critical minerals analyzed, China is the leading refiner for 19, with an average market share of about 70 percent. With its dominance in these markets, China's stringent export controls not only affect global prices and supply chains but also pose challenges to other countries' defense and high-tech sectors. While the impact of China's recent inclusion of technologies crucial for electric vehicle batteries in the Catalogue remains to be seen, the above cases illustrate China's broadening scope and growing use of export controls, as well as their potential implications for the global economy. The Paradox of Weaponizing Market Dominance Given the time required for alternative sourcing and technological breakthroughs, China retains considerable short-term leverage, not only through rare earths but via an increasingly broad set of other minerals and technologies. However, in the long run, China may face a dilemma: how to leverage its market dominance without eroding the trust and interdependence that underpin it. China's strategic use of export controls has sparked widespread global concerns. The United States, Europe, and other economies are now accelerating efforts to diversify supply sources and reduce their reliance on Chinese markets. For instance, at the June 2025 G-7 summit, leaders pledged to strengthen cooperation in securing the supply chains of critical minerals essential for high-tech and green industries, aiming to break China's grip. Chinese restrictions may also spur new competitive pressures from producers worldwide, especially those in Western countries. Recently, the U.S. has ramped up investment in building reliable domestic supply chains of materials such as rare earths and gallium, while deepening international collaboration with like-minded partners in Canada, Australia, Japan, and Europe. Given all these geoeconomic push-backs, the longer-term effectiveness of China's strategy, therefore, hinges on the pace at which the U.S. and its allies can secure viable alternatives and cultivate a post-China supply chain. Successful diversification would gradually weaken China's ability to weaponize interdependence, thereby undermining the very leverage it aims to preserve. When the U.S. imposed technology restrictions on China, many of its allies supported the move, making China the target of coordinated actions, especially in areas like high-end semiconductors. Now, as China attempts to leverage its dominance in areas where it has an advantage through export controls, Western countries are responding with collective efforts to reduce dependence on Chinese supply chains. This pattern suggests that China faces strategic disadvantages in using negative economic statecraft, given the broader geopolitical alignment against it. Conclusion China's export control regime has evolved from a loose policy mechanism into a precise and institutionalized instrument of economic statecraft. By tightening controls over technologies and mineral resources where it holds a competitive advantage, China can inflict economic pain on targets and gain a bargaining chip in international negotiations. However, in weaponizing interdependence, Beijing walks a fine line between asserting dominance and catalyzing the very diversification that could erode it. In the long run, it may confront a paradox: how can it preserve its leverage without accelerating the very decoupling it seeks to avoid?

China summons Nvidia over ‘backdoor safety risks' in H20 chips
China summons Nvidia over ‘backdoor safety risks' in H20 chips

Asahi Shimbun

time2 hours ago

  • Asahi Shimbun

China summons Nvidia over ‘backdoor safety risks' in H20 chips

Nvidia CEO Jensen Huang talks with Interior Secretary Doug Burgum, left, before President Donald Trump speaks during an AI summit at the Andrew W. Mellon Auditorium, July 23, 2025, in Washington. (AP Photo) WASHINGTON--China's cyberspace regulators on Thursday summoned Nvidia over security concerns that its H20 chips can be tracked and turned off remotely, the Cyberspace Administration of China said on its website. In the meeting, Chinese regulators demanded that the U.S. chip company provide explanations on 'backdoor safety risks' of its H20 chips to be sold in China and submit relevant materials, the office said. 'Cybersecurity is critically important to us. NVIDIA does not have 'backdoors' in our chips that would give anyone a remote way to access or control them,' an Nvidia spokesperson said in a statement to AP. It came just about two weeks after the Trump administration lifted the block on the computing chips and allowed Nvidia to resume sales of H20 chips to the Chinese market. Jensen Huang, chief executive of Nvidia, made the announcement with fanfare when he was in Beijing earlier this month. The latest episode appears to be another turbulence in the tech rivalry between the United States and China, which have left businesses in both countries tussling with governments over market access and national security concerns. Any safety concern by Beijing could jeopardize the sale of H20 chips in China. Citing unnamed U.S. AI experts, the Chinese regulators said Nvidia has developed mature technology to track, locate and remotely disable its computing chips. The regulators summoned Nvidia to 'safeguard the cybersecurity and data security of Chinese users,' in accordance with Chinese laws, the statement said. The statement also referred to a call by U.S. lawmakers to require tracking and locating capabilities on U.S. advanced chips sold overseas. In May, Rep. Bill Huizenga, R.-Michigan, and Rep. Bill Foster, D.-Illinois, introduced the Chip Security Act that would require high-end chips to be equipped with 'security mechanisms' to detect 'smuggling or exploitation.' The bill has not moved through Congress since its introduction. Foster, a trained physicist, then said, 'I know that we have the technical tools to prevent powerful AI technology from getting into the wrong hands.' The U.S. still bans the sale to China of the most advanced chips, which are necessary for developing artificial intelligence. Both countries aim to lead in the artificial intelligence race. The Trump administration in April blocked the sales of H20 chips, which Nvidia developed to specifically comply with U.S. restrictions for exports of AI chips to China. After the ban was lifted, Nvidia expected to sell hundreds of thousands more H20 chips in the Chinese market. But the easing of the ban has raised eyebrows on Capitol Hill. On Monday, a group of top Democratic senators, including Minority Leader Sen. Chuck Schumer, wrote to Commerce Secretary Howard Lutnick to express their 'grave concerns.' While chips like the H20 have differing capabilities than the most advanced chips such as Nvidia's H100, 'they give (China) capabilities that its domestically-developed chipsets cannot,' the senators wrote. Shortly after the ban was lifted, Rep. John Moolenaar, R.-Michigan, who chairs the House Select Committee on China, objected. 'The Commerce Department made the right call in banning the H20. Now it must hold the line,' Moolenaar wrote in a letter to Lutnick. 'We can't let the CCP use American chips to train AI models that will power its military, censor its people, and undercut American innovation,' Moolenaar wrote, referring to the Chinese Communist Party by its acronym.

Unverified Information on Tsunami Spreads on Social Media; Japan Govt Urges Caution over Misinformation
Unverified Information on Tsunami Spreads on Social Media; Japan Govt Urges Caution over Misinformation

Yomiuri Shimbun

timea day ago

  • Yomiuri Shimbun

Unverified Information on Tsunami Spreads on Social Media; Japan Govt Urges Caution over Misinformation

False footage and unverified information spread on social media following tsunami warnings issued by the Japan Meteorological Agency on Wednesday, prompting the government to urge people to remain cautious about such content. Footage showing a massive tsunami, taller than a high-rise building, crashing onto the Japanese coast was posted on X. The video, which appeared to be generated by the AI, had been viewed about 330,000 times as of 8 p.m. on Wednesday. A prophecy predicting that a disaster would occur on July 5 had been circulating in Japan and China. After tsunami warnings were issued, some people posted claims saying that the prophecy had come true. The Internal Affairs and Communications Ministry posted a message on X urging people to remain cautious about false information and misinformation, saying, 'There is a risk of unverified information being distributed on the internet, such as claims that have no scientific basis.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store